Is it possible to control hyperphosphataemia with diet, without inducing protein malnutrition?

被引:81
作者
Rufino, M
de Bonis, E
Martin, M
Rebollo, S
Martin, B
Miquel, R
Cobo, M
Hernandez, D
Torres, A
Lorenzo, V [1 ]
机构
[1] Hosp Univ Canarias, Serv Nefrol, Tenerife 38320, Spain
[2] Hosp Tamaragua, Nephrol Sect, Tenerife, Spain
关键词
chronic haemodialysis; dietary phosphorus; hyperphosphataemia; malnutrition; protein intake;
D O I
10.1093/ndt/13.suppl_3.65
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Dietary intervention, phosphate (P) removal during dialysis and, especially, phosphate binders are current methods for the management of hyperphosphataemia. Ideally, the amount of P absorbed from the diet should equal the amount of P removed during dialysis, and this must occur in the context of an adequate protein intake. We evaluated the relationship between P intake and protein intake in 60 stable chronic uraemic patients (mean age 55 +/- 15 years, 25% diabetics, 68% males) on standard 4 h haemodialysis. The dietary counselling was relatively free for protein and calories. Nutrient intake was recorded during a 5 day period, and average daily ingestion of P and proteins was calculated using a computerized diet analysis system. A highly significant correlation was observed between protein and P intake. The mean daily ingestion of P and proteins was 998 +/- 316 mg and 64 +/- 19 g (1 +/- 0.4 g/kg/day), respectively. For an optimal protein diet of 1-1.2 g/kg/day, the P intake was 778-1444 mg. The amount of P removed by haemodialysis, extrapolated to an average week, is 250-300 mg/day. Since similar to 40% of P ingested is absorbed from the gut by uraemic patients treated with intestinal P binders, 750 mg of P intake should be the critical value above which a positive balance of P may occur. This value corresponds to a protein intake of 45-50 g per day (>0.8 g/kg body weight/day for a 60 kg patient). In patients undergoing standard chronic haemodialysis, a neutral P balance is difficult to achieve, despite phosphate binder therapy, when protein intake is > 50 g. Additional protein restriction, in order to obtain a neutral balance, may impose the risk of protein malnutrition.
引用
收藏
页码:65 / 67
页数:3
相关论文
共 14 条
[1]  
ARISI L, 1987, SHORT DIALYSIS, P149
[2]   NITROGEN-BALANCE DURING INTERMITTENT DIALYSIS THERAPY OF UREMIA [J].
BORAH, MF ;
SCHOENFELD, PY ;
GOTCH, FA ;
SARGENT, JA ;
WOLFSON, M ;
HUMPHREYS, MH .
KIDNEY INTERNATIONAL, 1978, 14 (05) :491-500
[3]  
COBURN JW, 1977, CALCIUM METABOLISM R, P77
[4]   HYPERPHOSPHATEMIA - ITS CONSEQUENCES AND TREATMENT IN PATIENTS WITH CHRONIC RENAL-DISEASE [J].
DELMEZ, JA ;
SLATOPOLSKY, E .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1992, 19 (04) :303-317
[5]  
HERCZ G, 1987, KIDNEY INT, V32, pS215
[6]   PROTEIN-REQUIREMENTS IN MAINTENANCE HEMODIALYSIS [J].
KLUTHE, R ;
LUTTGEN, FM ;
CAPETIANU, T ;
HEINZE, V ;
KATZ, N ;
SUDHOFF, A .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 1978, 31 (10) :1812-1820
[7]  
LORENZO V, 1995, NEPHROL DIAL TRANSPL, V10, P1885
[8]   CALCIUM ACETATE, AN EFFECTIVE PHOSPHORUS BINDER IN PATIENTS WITH RENAL-FAILURE [J].
MAI, ML ;
EMMETT, M ;
SHEIKH, MS ;
SANTAANA, CA ;
SCHILLER, L ;
FORDTRAN, JS .
KIDNEY INTERNATIONAL, 1989, 36 (04) :690-695
[9]   CONTROL OF HYPERPHOSPHATEMIA IN CHRONIC-RENAL-FAILURE [J].
MORTON, AR ;
HERCZ, G ;
COBURN, JW .
SEMINARS IN DIALYSIS, 1990, 3 (04) :219-223
[10]  
PANZETTA G, 1990, NEPHROL DIAL TRANSPL, V5, P125